Clinical Trials · NCT04522622
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Ditte Hansen
- Enrollment
- 48
- Start date
- Dec 2021
- Locations
- 4 sites, Denmark
- Primary endpoint
- Changes in bone specific alkaline phosphatase (BSAP)